Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Total article views   Abstract views HTML views PDF downloads Totals
18,770 Dovepress* 9,031 2,014+ 1,845 11,045
PubMed Central* 0 7,725 773 7,725
Totals 9,031 9,739 2,618 18,770
*Since 8 January 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
40 2 0 0 17 21

View citations on PubMed Central and Google Scholar